Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02914587

Enrollment

Registered

2016-09-26

Start date

2016-08-31

Completion date

2017-10-31

Last updated

2017-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic Alopecia

Brief summary

To investigate and compare the safety and effectiveness of the ARTAS™ System to manual hair follicle implantation method following a nine month period of post-procedure evaluation.

Detailed description

This comparative study is a multi-center, prospective, blinded, randomized controlled clinical study where subjects act as their own control. The purpose of this study is to demonstrate that the ARTAS System is safe and effective for implanting follicular hair units. Patients will be followed for a nine months period of time.

Interventions

DEVICEARTAS System

OTHERManual Implantation

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

MALE

Age

29 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Subject is male with clinical diagnosis of androgenetic alopecia with Norwood-Hamilton grade of IV-VI; * Subject is 29 to 70 years old; * Subject has black or brown hair color; * Subject has straight hair; * Subject agrees to cut hair short (about 1-1.4 mm) on the scalp in the designated study areas for harvesting and implantation; * Subject agrees to have 6 dot tattoos placed on scalp; * Subject is able to understand and provide written consent; and * Subject consents to post-operative follow-up per protocol.

Exclusion criteria

* Subject has prior history of scalp reduction surgery(s); * Subject has prior history of hair restoration procedure(s) using the strip excision technique; * Subject has bleeding diathesis; * Subject has active use of anti-coagulation medication; * Subject has used finasteride in the previous 6 months, or plans to use finasteride during the study; * Subject has used minoxidil in the previous 2 weeks, or plans to use minoxidil during the study; or * Subject has any other condition that, in the opinion of the investigator, makes the subject inappropriate to take part in this study.

Design outcomes

Primary

Measure	Time frame	Description
Hair Survival rate 9-months post procedure	9 month	Hair survival rate

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026